why choose us

Clinical Trials Search

Showing 6,040 of 132,085 result(s)
Pilot Feasibility Study of a Novel Non-invasive Device for Diagnosis of Anemia

Status: NOT_YET_RECRUITING

Condition: Anemia

Interventions: The Anemia Diagnostic Assistant is non-invasive and simultaneously detects two markers of anemia, blood hemoglobin and the End-Tidal carbon monoxide l

Date: 2023-11-28

Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45

Status: NOT_YET_RECRUITING

Condition: Migraine

Interventions: The intervention will be active medication.

Date: 2023-11-28

Balance Targeted Exercises for Individuals With MS

Status: Completed

Condition: Multiple Sclerosis

Interventions: 6-week exercise program, 3 sessions per week (2 sessions in person, 1 session of home exercises.
Participants will receive a booklet with informa

Date: 2023-11-28

Evaluation Of The Effect Of Spinal Orthosis On Tactile Sense And Balance In Individuals With Lumbal Curve And Adolescent Idiopathic Scoliosis

Status: Completed

Condition: Adolescent Idiopathic Scoliosis

Interventions: Spinal orthosis treatment is to prevent secondary curvature and provide correction.
Corrective pressure forces in spinal orthosis are basically;

Date: 2023-11-28

A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects

Status: Completed

Condition: Healthy Male Volunteers

Interventions: A single dose (0.3 mg;kg) of HLX13 via intravenous infusion.

Date: 2023-11-28

Effects of Peanuts on Immunity and Cardiometabolic Risk Factors

Status: COMPLETED

Condition: Immune Response

Interventions: Participants will consume 2 ounces of peanuts;peanut butter for 12 weeks

Date: 2023-11-28

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

Status: Completed

Condition: Breast Cancer

Interventions: Week 1 50mg orally BID

Date: 2023-11-28

A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema

Status: Completed

Condition: Diabetic Macular Edema

Interventions: An intravitreal injection of 50 microliters at the doses described will be given.
Visual acuity, optical coherence tomography thickness and vascu

Date: 2023-11-28

Short Practices Well-being Study

Status: COMPLETED

Condition: Well-Being, Psychological

Interventions: Participants will listen to recordings of short meditation practices drawn from the Healthy Minds Program.

Date: 2023-11-28

A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer

Status: NOT_YET_RECRUITING

Condition: Breast Cancer

Interventions: BB-1701 will be administered as an intravenous infusion, every 3 weeks (21-day cycle).

Date: 2023-11-28